¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Rust's disease, phenomenon"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • hepatolenticular disease
    °£·»ÁîÇÙº´
  • hereditary disease
    À¯Àüº´
  • heredodegenerative disease
    À¯Àüº¯¼ºº´
  • herpetic disease
    Ç츣Æä½ºº´
  • hidebound disease
    Çǰñ»óÁ¢º´
  • hip-joint disease
    ¾ûµ¢°üÀýº´, °í°üÀýº´
  • Hirschsprung¡¯s disease
    È÷¸£½´½´ÇÁ·îº´
  • hand-foot-mouth disease
    ¼Õ¹ßÀÔº´
  • Hand-Schuller-Christian disease
    ÇÚµå-½¯·¯-Å©¸®½ºÃµº´
  • Hodgkin¡¯s disease
    È£ÁöŲº´
  • holoendemic disease
    ¼Ò¾ÆÇ³Å亴
  • hookworm disease
    ±¸Ã溴
  • Hansen¡¯s disease
    ÇѼ¾º´
  • hunger disease
    ±â¾Æº´
  • hyaline membrane disease
    À¯¸®Áú¸·º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • hookworm disease
    ±¸Ã溴
  • hunger disease
    ±â¾Æº´
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • hydatid disease
    Æ÷Ãæº´
  • hyperbaric disease
    °í¾Ðº´
  • hyperendemic disease
    °ú´ÙºóµµÇ³Å亴
  • hypertensive disease
    °íÇ÷¾ÐÁúȯ
  • hypertensive heart disease
    °íÇ÷¾Ð½ÉÀ庴, °íÇ÷¾Ð½ÉÀåÁúȯ
  • hypertensive vascular disease
    °íÇ÷¾ÐÇ÷°üº´
  • iatrogenic disease
    ¿øÀÎºÒ¸íº´
  • idiopathic disease
    Ư¹ßº´, Àڹߺ´
  • immune deposit disease
    ¸é¿ªÄ§Âøº´
  • immune-complex disease
    ¸é¿ªº¹ÇÕüº´
  • immunodeficiency disease
    ¸é¿ª°áÇ̺´
  • immunological disease
    ¸é¿ªÁúȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • Lyme disease
    ¶óÀÓ Áúȯ
  • Lyme disease
    ¶óÀÓº´
  • Lymes disease
    ¶óÀÓ½ºº´
  • Mareks disease virus
    ¸¶·ºº´¹ÙÀÌ·¯½º
  • Menieres disease
    ¸Þ´Ï¿¡¸£º´
  • Mikuliczs disease
    ¹ÌÄð¸®Ã÷º´
  • Mondors disease
    ¸óµµ¸£ º´
  • Mu heavy chain disease
    Mu Áß¼âÁúȯ
  • Oguchis disease
    ¿À±¸Ä¡º´
  • Osler-Weber-Rendu disease
    ¿À½½·¯-¿þ¹ö-·»µÎ¾¾ º´
  • Pagets disease
    ÆÄÁ¦Æ®º´
  • Pagets disease
    ÆÄÁ¦Æ®º´.
  • Pagets disease
    ÆÄÁ¦Æ®º´
  • Pagets disease, extramammary
    À¯¹æ¿Ü ÆÄÁ¦Æ®º´.
  • Parkinsons disease
    ÆÄŲ½¼º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • aviation disease
    Ç×°øº´(ÊÙËÓ).
  • aviators disease
    Ç×°øº´.
  • bacterial disease
    ¼¼±ÕÁúȯ
  • bacterial disease
    ¼¼±Õ¼º Áúȯ(¡­òðü´)
  • bacterial disease
    ¼¼±Õ¼º Áúȯ(¡­òðü´).
  • bauxite fume disease
    º¸¿ÀÅ©»çÀÌÆ® Áõ±âº´.
  • bergers disease
    ¹ö°Åº´(¡­Ü»)
  • beriberi heart disease
    °¢±â½ÉÁúȯ(ÊÅѨãýòðü´)
  • beriberi heart disease
    °¢±â½ÉÁúȯ.
  • biliary tract disease
    ´ãµµÁúȯ
  • bird fanciers disease
    Á¶·ù»çÀ°ÀÚº´.
  • bird fanoiers disease
    Á¶·ù»çÀ°ÀÚº´(ðè×¾ÞøëÀí­Ü»)
  • black disease
    ±«»ç¼º °£¿°(ÎÕÞÝàõÊÜæú) ¡ì¾çÀÇ¡í.
  • black disease
    ±«»ç¼º °£¿°(ÎÕÞÝàõÊÜæú) ¡ì¾çÀÇ¡í.
  • black jaundice =Winckels disease
    ÈæÈ²´Þ(ÈæÈ²´Þ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
DPD Department of Public Dispensary; depression pure disease; desoxypyridoxine; diffuse pulmonary diseas...
ED early-decision [applicant]; early differentiation; ectodermal dysplasia; ectopic depolarization; eff...
GSD genetically significant dose; Gerstmann-Straussler disease; glutathione synthetase deficiency; glyco...
HLD hepatolenticular degeneration; herniated lumbar disk; Hippel-Lindau disease; hypersensitivity lung d...
IBD inflammatory bowel disease; irritable bowel disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
CMT1A Charcot-Marie Tooth disease type 1A
CMTD Charcot-Marie-Tooth Disease
CMT-X Charcot-Marie-Tooth disease
CESD Cholesterol ester storage disease
CLD Chronic Lung Disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Marchiafava-Bignami disease
    ¸¶¸£Å°¾ÆÆÄ¹Ù-ºñ³Ä¹Ì º´
    ³ú·®ÀÇ ÁøÇ༺ ÅðÇà º¯¼ºÀ¸·Î¼­ ÁøÇ༺ ÁöÀû ȲÆó, Á¤¼­ Àå¾Ö, Âø¶õ, ȯ°¢, ÁøÀü, °­Á÷, °æ·ÃÀÌ Æ¯Â¡. ÁÖ·Î Á߳⠳²ÀÚ Áß ¾ËÄÝ Áßµ¶ÀÚ, ƯÈ÷ ´Ù·®ÀÇ »ýÆ÷µµÁÖ¸¦ ¸¶½Ã´Â »ç¶÷¿¡°Ô Àß °É¸®´Â µå¹® Áúº´ÀÌ´Ù.
  • Marek's disease
    ¸¶·¹Å© º´
    Æ÷Áø ¹ÙÀÌ·¯½º
  • margarine disease
    ¸¶°¡¸° º´
    ´ÙÇü¼º È«¹ÝÀ¸·Î¼­ oleomargarineÁßÀÇ À¯È­Á¦°¡ ¿øÀÎÀÌ´Ù. µ¶ÀÏ, ¿À¶õ´Ù¿¡¼­ Æø¹ßÀûÀ¸·Î À¯ÇàÇÏ¿´À¸¸ç ´ç½Ã´Â Àü¿°¼ºÀ̶ó°í »ý°¢Çß´Ù.
  • medullary cystic disease
    ¼öÁú³¶¼º Áúȯ
  • mental disease
    Á¤½Åº´
    ±â´ÉÀû ¿øÀΰú ±âÁúÀûÀÎ ¿øÀÎÀ» Æ÷ÇÔÇÑ ¸ðµç Á¤½Åº´.
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
  • metabolic disease
    ´ë»ç¼º Áúȯ
    ½Åü ¼¼Æ÷ÀÇ È­ÇйÝÀÀÀÇ Àå¾Ö°¡ ¿øÀÎÀÌ µÇ´Â Áúȯ.
  • Mikulicz's disease
    ¹ÌŬ¸¯Âê¾¾º´, ¹ÌÄð¸®Ã÷º´
    ¹ÌÁöÀÇ ¿øÀο¡ ÀÇÇÑ ´©¼± ¹× Ÿ¾×¼±ÀÇ ¾ç¼º ÀÚ±â ÇÑÁ¤¼º ¸²ÇÁ±¸ ħÀ±°ú Á¾Ã¢À¸·Î¼­, Á߳⠶Ǵ ³ë³âÀÇ ºÎÀο¡°Ô ¹ßº´ÇÑ´Ù. Sjögren ÁõÈıº°ú µ¿ÀÏÇÏ´Ù°í »ý°¢ÇÏ´Â »ç¶÷µéµµ ÀÖ´Ù. ¶Ç´Â °øÅëÀÇ º´ÀÎÀ» °¡Áø µ¿ÀÏ ÁúȯÀÇ ÀÌÇüÀ̶ó°í ÇÏ´Â »ç¶÷µµ ÀÖ´Ù. À¯À°Á¾Áõ, ¾Ç¼º ¸²ÇÁÁ¾, ±³¿øº´ µî¿¡¼­ µ¿ÀÏÇÑ ÀÓ»ó ¼Ò°ßÀ» º¼ ¶§, Mikulicz ÁõÈıºÀ̶ó°í ÇÑ´Ù.
  • mitral valvular disease
    ½Â¸ðÆÇ¸· Áúȯ
  • molecular disease
    ºÐÀÚ º´
    Ç÷»ö¼Ò ºÐÀÚÀÇ ±Û·Îºó ÀÌ»ó¿¡ ÀÇÇÑ ÀÌ»ó Ç÷»ö¼ÒÀÇ Á¸Àç¿¡ ÀÇÇØ ¹ß»ýÇϴ Ư¼öÇÑ ºóÇ÷¿¡ ´ëÇÏ¿© PaulingÀÌ ºÙÀÎ ¸íĪ.
  • motor neuron disease
    ¿îµ¿ ´º·± Áúȯ
    ¿îµ¿ ½Å°æ¿ø¼º Áúȯ, ¿îµ¿ ½Å°æ ´º·±ÀÇ ÁúȯÀ¸·Î¼­ ô¼ö ½Å°æ À§Ãà, ÁøÇ༺ ±¸»ó ¸¶ºñ, ±ÙÀ§Ã༺ Ãà»è °æÈ­Áõ, Ãà»è °æÈ­Áõ µîÀ» ¸ðµÎ Æ÷ÇÔÇÑ´Ù.
  • motor neurone disease
    ¿îµ¿ ½Å°æ¿ø¼º Áúȯ
  • motor system disease
    ¿îµ¿°è Àå¾Ö
  • mountain disease
    °í»êº´, »ê¾Çº´, »ê¸Ö¹Ì
    Àú»ê¼ÒÁõÀ» ÀÏÀ¸Å°±â¿¡´Â ÃæºÐÇÑ °í¼Ò¿¡ ³ëÃâµÊÀ¸·Î½á ÀϾ´Â ÁõÈıºÀ¸·Î¼­, °¨¼ÒµÈ ´ë±â¾Ð°ú ÀÌ¿¡ µû¸£´Â µ¿¸ÆÇ÷ÀÇ »ê¼Ò ÇÔ·® ÀúÇÏÀÇ °á°ú·Î ÀϾ´Ù. ±Þ¼ºÇü
  • Moyamoya disease
    ¸ð¾ß¸ð¾ß º´
    1. ³»°æ µ¿¸Æ ¸»´ÜºÎ¿¡ ÇùÂø, Æó»öÀÇ ¾ç»óÀÌ ³ªÅ¸³ª´Â Áúȯ.Àª¸®½º µ¿¸Æ·û Æó»öÁõ, ³úÀúºÎ ÀÌ»ó Ç÷°ü¸ÁÁõÀ̶ó°íµµ ÇÑ´Ù. µ¹¹ß¼º ³ú Ç÷°ü ºÎÀüÁõ¿¡¼­ º¼ ¼ö Àִµ¥ ³ú ÀúºÎÀÇ Á¤»ó Ç÷°ü ´ë½Å¿¡ ¼Òµ¿¸ÆÀÇ Èñ¹ÌÇÑ ±×¹° ¸ð¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
asbestos lung disease <radiology> Pleural plaques, earliest finding, may be only evidence, parietal pleura, 15-20 yrs after exposure, calcified after ca. 30 yrs, asbestosis, interstitial lung disease, perihilar regions to lung bases, shaggy heart, no cavitation or progressive massive fibrosis as in silicosis, crocidolite (blue) form most carcinogenic, associated with: malignant pleural mesothelioma, peritoneal mesothelioma, GI-tract malignancy
(12 Dec 1998)
asherman disease <radiology> Uterine synechiae, linear, lucent defects in uterus on HSG, usually secondary to endometrial trauma (D&C, etc.)
(12 Dec 1998)
atherosclerotic vascular disease <cardiology> The progressive narrowing and hardening of the arteries over time. This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
Aujeszky's disease A highly contagious herpes virus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.
(12 Dec 1998)
Aujeszky's disease virus A herpesvirus causing pseudorabies in swine.
Synonym: Aujeszky's disease virus.
(05 Mar 2000)
Australian X disease A severe encephalitis with a high mortality rate occurring in the Murray Valley of Australia; the disease is most severe in children and is characterised by headache, fever, malaise, drowsiness or convulsions, and rigidity of the neck; extensive brain damage may result; it is caused by the Murray Valley encephalitis virus (genus Flavivirus).
Synonym: Australian X disease, Australian X encephalitis.
(05 Mar 2000)
Australian X disease virus A group B arbovirus of the genus Flavivirus that causes Murray Valley encephalitis; it is transmitted by Culex mosquitoes, and also infects birds and horses.
Synonym: Australian X disease virus, MVE virus.
(05 Mar 2000)
autoimmune disease <disease> A disease process that involves the production of host antibodies to host tissue.
(27 Sep 1997)
aviator's disease Syndrome resembling decompression sickness occurring in occupants of airplanes that reach very high altitudes without adequate pressurization of the cabin.
See: decompression sickness.
(05 Mar 2000)
Ayerza's disease <syndrome> Sclerosis of the pulmonary arteries in chronic cor pulmonale; associated with severe cyanosis, it is a condition resembling polycythemia vera but resulting from primary pulmonary arteriosclerosis or primary pulmonary hypertension and characterised by plexiform lesions of arterioles.
Synonym: Ayerza's disease, cardiopathia nigra, plexogenic pulmonary arteriopathy.
(05 Mar 2000)
Azorean disease A rare form of hereditary ataxia, characterised by onset in early adult life of progressive, spinocerebellar and extrapyramidal disease with external ophthalmoplegia, rigidity dystonia symptoms, and, often, peripheral amyotrophy; found predominantly in people of Azorean ancestry; autosomal dominant inheritance.
Synonym: Azorean disease, Portuguese-Azorean disease.
Origin: Surnames of two families studied in major descriptions of the disease.
(05 Mar 2000)
bacterial wilt disease <botany> A plant disease common in cucumber and muskmelon caused by the bacteria Erwinia tracheiphila which causes wilting and shriveling of the stems and leaves.
(09 Oct 1997)
Baelz' disease An acquired disorder, of unknown aetiology, of the lower lip characterised by swelling, ulceration, crusting, mucous gland hyperplasia, abscesses, and sinus tracts.
Synonym: Baelz' disease, myxadenitis labialis, Volkmann's cheilitis.
(05 Mar 2000)
Balo's disease Encephalitis that is clinically similar to adrenoleukodystrophy, but pathologically characterised by concentric globes or circles of demyelination of cerebral white matter separated by normal tissue.
Synonym: Balo's disease.
(05 Mar 2000)
Baltic myoclonus disease One of the familial light sensitive myoclonic epilepsies. Unlike Lafora body polymyoclonus, where inclusion bodies are seen in the brain cells, the prognosis is often favourable. Probably an autosomal recessive disorder.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á